NCT05539677 Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research Status RECRUITING Phase N/A
NCT05539300 PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide Status RECRUITING Phase NA
NCT05533515 Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer Status COMPLETED Phase N/A
NCT05530655 A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer Status RECRUITING Phase EARLY_PHASE1
NCT05527483 Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients Status COMPLETED Phase N/A
NCT05523856 New Treatment Modalities for Localized Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05522907 Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer Status NOT_YET_RECRUITING Phase N/A
NCT05521412 EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T Status RECRUITING Phase PHASE1/PHASE2
NCT05520255 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028 Status RECRUITING Phase PHASE3
NCT05519449 Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) Status RECRUITING Phase PHASE1
NCT05518799 CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours Status COMPLETED Phase NA
NCT05516329 Study of 18F-Thretide PET/CT in Patients With Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05515978 Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients Status RECRUITING Phase EARLY_PHASE1
NCT05512663 Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer Status UNKNOWN Phase NA
NCT05506735 The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History Status COMPLETED Phase N/A
NCT05501548 Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT05500846 Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial Status ACTIVE_NOT_RECRUITING Phase NA